11-113206819-A-G

Variant names:

• chr11-113206819-A-G
• rs1821693
• NM_181351.5:c.629-442A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_181351.5(NCAM1):​c.629-442A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.495 in 152,064 control chromosomes in the GnomAD database, including 19,675 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.49 (19675 hom., cov: 32)
• Consequence: NCAM1 NM_181351.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.690
• Publications: 10 publications found

Genes affected

NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181351.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	NM_181351.5	MANE Select	c.629-442A>G		intron	N/A	NP_851996.2
	NCAM1	NM_001400624.1		c.629-442A>G		intron	N/A	NP_001387553.1
	NCAM1	NM_001400620.1		c.629-442A>G		intron	N/A	NP_001387549.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	NCAM1	ENST00000316851.12	TSL:5 MANE Select	c.629-442A>G		intron	N/A	ENSP00000318472.8
	NCAM1	ENST00000529356.5	TSL:1	c.629-442A>G		intron	N/A	ENSP00000482205.1
	NCAM1	ENST00000619839.4	TSL:5	c.629-442A>G		intron	N/A	ENSP00000480132.1

Frequencies

GnomAD3 genomes AF: 0.494 AC: 75130 AN: 151944 Hom.: 19630 Cov.: 32

Gnomad AFR AF: 0.633

Gnomad AMI AF: 0.283

Gnomad AMR AF: 0.501

Gnomad ASJ AF: 0.433

Gnomad EAS AF: 0.729

Gnomad SAS AF: 0.498

Gnomad FIN AF: 0.330

Gnomad MID AF: 0.449

Gnomad NFE AF: 0.423

Gnomad OTH AF: 0.475

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.495 AC: 75234 AN: 152064 Hom.: 19675 Cov.: 32 AF XY: 0.493 AC XY: 36653 AN XY: 74344

African (AFR) AF: 0.633 AC: 26271 AN: 41470

American (AMR) AF: 0.501 AC: 7667 AN: 15290

Ashkenazi Jewish (ASJ) AF: 0.433 AC: 1503 AN: 3468

East Asian (EAS) AF: 0.728 AC: 3757 AN: 5160

South Asian (SAS) AF: 0.497 AC: 2397 AN: 4826

European-Finnish (FIN) AF: 0.330 AC: 3489 AN: 10578

Middle Eastern (MID) AF: 0.449 AC: 132 AN: 294

European-Non Finnish (NFE) AF: 0.423 AC: 28742 AN: 67952

Other (OTH) AF: 0.482 AC: 1018 AN: 2114

Alfa AF: 0.455 Hom.: 43405

Bravo AF: 0.514

Asia WGS AF: 0.635 AC: 2204 AN: 3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
CADD	Benign	0.77
DANN	Benign	0.50
PhyloP100		0.69
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs1821693; hg19: chr11-113077541;